Author:
Lemes J.A.,Silva M.S.C.F.,Gonçalves B.S.M.,Céspedes I.C.,Viana M.B.
Reference51 articles.
1. Santomauro, D.F., Herrera, A.M.M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D.M., Abbafati, C., Adolph, C., Amlag, J.O., Aravkin, A.Y. et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet 398 (2021) 1700–1712.
2. Epidemiologia dos transtornos de ansiedade em regiões do Brasil: uma revisão de literatura;Mangolini;Rev. De Med.,2019
3. Pharmacotherapy of anxiety disorders: current and emerging treatment options;Garakani;Front. Psychiatry,2020
4. The human raphe nuclei and the serotonergic system;Hornung;J. Chem. Neuroanat.,2003
5. Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence;Calizo;Neuropharmacology,2011